
B/m/vinci8/data1/riedel/corpora/nyt/nyt/data/2005/01/20/1643457.xml£


ADTO

BritishJJO

drugNNO

	developerNNO
	
,,O

OxfordNNPORGANIZATION

	BioMedicaNNPORGANIZATION
	
,,O

saidVBDO

itPRPO

wasVBDO

inINO

discussionsNNSO

withINO

anDTO

unidentifiedJJO

thirdJJO

partyNNO

aboutINO


aDTO

	potentialJJO

mergerNNO
	
..O‚€€€øÿÿÿÿ *ORGANIZATION´

TheDTO

companyNNO

makesVBZO


gene-basedJJO


treatmentsNNSO

forINO

cancerNNO

andCCO

neurologicalJJO

diseasesNNSO
	
,,O

	includingVBGO

TroVaxNNPORGANIZATION
	
,,O


aDTO

vaccineNNO

forINO

tumorsNNSO

thatWDTO

isVBZO

inINO

clinicalJJO

trialsNNSO
	
..Oƒ€€€øÿÿÿÿ *ORGANIZATION¦

MergerNNPO

discussionsNNSO

areVBPO

atINO

anDTO

earlyJJO

stageNNO
	
,,O

andCCO

mayMDO

notRBO

leadVBO

toTOO

anDTO

offerNNO
	
,,O

theDTO

companyNNO

saidVBDO
	
..O·

SharesNNSO

inINO

OxfordNNPORGANIZATION

	BioMedicaNNPORGANIZATION

roseVBDO

18.2CDO

percentNNO
	
..O„€€€øÿÿÿÿ *ORGANIZATIONZ

HeatherNNO

TimmonsNNPO

-LRB--LRB-O

NYTNNPO

-RRB--RRB-O